The importance of carnitine goes beyond just energy production
Erratum in: J Am Coll Cardiol 2012;59(24):2306 Eagle KA, Berger PB, Calkins H, Chaitman BR, Ewy GA, Fleischmann KE, et al
Suitability depends on individual medical assessment
The STEP 1 trial (N=1,961) demonstrated that semaglutide 2.4 mg produced 14.9% mean body weight reduction at 68 weeks versus 2.4% with placebo [7]
That third lever is the whole bet
Many healthcare professionals are concerned that those with restrictive eating disorders should not be on appetite-suppressant drugs, says Pamela Keel, a psychologist and eating disorder expert at Florida State University